Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03558230 · ClinicalTrials.gov registry record · NA

Sensory Stimulation During CIMT

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT03558230: Completed NA study, sponsored by Medical University of South Carolina.

NCT03558230 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03558230, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The long-term goal of this project is to assess the impact of the novel sensory stimulation technique in enhancing outcomes of constraint-induced movement therapy (CIMT) in children with cerebral palsy. This is a pilot project.

Primary Outcome

total number of hours that participants wear the device

Interventions

  • BEHAVIORAL Standardized Constraint-Induced Movement Therapy
  • BEHAVIORAL Vibration
  • BEHAVIORAL Placebo (for vibration)

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2018-07-16
Est. Completion 2018-10-28
Phase NA

What the finished NCT03558230 record still lists

NCT03558230 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Standardized Constraint-Induced Movement Therapy is the first listed.

NCT03558230 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03558230 about?

NCT03558230 is a clinical study titled "Sensory Stimulation During CIMT". The long-term goal of this project is to assess the impact of the novel sensory stimulation technique in enhancing outcomes of constraint-induced movement therapy (CIMT) in children with cerebral palsy. This is a pilot project.

What is the current status of trial NCT03558230?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2018-07-16. Estimated completion is 2018-10-28.

What interventions are being tested in trial NCT03558230?

The interventions under investigation include: Standardized Constraint-Induced Movement Therapy (BEHAVIORAL), Vibration (BEHAVIORAL), Placebo (for vibration) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03558230?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03558230's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03558230, the US trial registry maintained by the National Library of Medicine. NCT03558230 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.